In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
Non-US residents click here.


HYMPAVZI™ How should I use HYMPAVZI?

(marstacimab-hncq)

How should I use HYMPAVZI?

See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.

Use HYMPAVZI exactly as prescribed by your healthcare provider.
Your healthcare provider will provide instructions for stopping (discontinuing) your current treatment when switching from factor- or non-factor-based medicines to HYMPAVZI.
HYMPAVZI is given as an injection under your skin (subcutaneous injection) by you or your caregiver.
Your healthcare provider should show you or your caregiver how to inject HYMPAVZI before you inject yourself for the first time.
Do not attempt to inject yourself or another person unless you have been taught how to do so by a healthcare provider.
Your first dose (loading dose) of HYMPAVZI is 300 mg (two 150 mg injections). Then you will inject a weekly (maintenance) dose as prescribed by your healthcare provider.
Inject HYMPAVZI 1 time a week on the same day each week. Inject HYMPAVZI at any time of day.
Your healthcare provider will provide information on the treatment of breakthrough bleeding during your treatment with HYMPAVZI. Do not use HYMPAVZI to treat breakthrough bleeding.
If you miss a maintenance dose of 150 mg of HYMPAVZI:
o
Give the dose as soon as possible before the next scheduled dose, and then continue with your usual 150 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.
o
If more than 13 days have passed since your last dose was given, call your healthcare provider right away for dosing instructions.
If you miss 1 or more doses of maintenance dose of 300 mg of HYMPAVZI:
o
Give a dose as soon as possible, and then continue with your 300 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.

Find HYMPAVZI™ medical information:

Find HYMPAVZI™ medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

HYMPAVZI™ Quick Finder

Health Professional Information

How should I use HYMPAVZI?

How should I use HYMPAVZI?

See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.

Use HYMPAVZI exactly as prescribed by your healthcare provider.
Your healthcare provider will provide instructions for stopping (discontinuing) your current treatment when switching from factor- or non-factor-based medicines to HYMPAVZI.
HYMPAVZI is given as an injection under your skin (subcutaneous injection) by you or your caregiver.
Your healthcare provider should show you or your caregiver how to inject HYMPAVZI before you inject yourself for the first time.
Do not attempt to inject yourself or another person unless you have been taught how to do so by a healthcare provider.
Your first dose (loading dose) of HYMPAVZI is 300 mg (two 150 mg injections). Then you will inject a weekly (maintenance) dose as prescribed by your healthcare provider.
Inject HYMPAVZI 1 time a week on the same day each week. Inject HYMPAVZI at any time of day.
Your healthcare provider will provide information on the treatment of breakthrough bleeding during your treatment with HYMPAVZI. Do not use HYMPAVZI to treat breakthrough bleeding.
If you miss a maintenance dose of 150 mg of HYMPAVZI:
o
Give the dose as soon as possible before the next scheduled dose, and then continue with your usual 150 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.
o
If more than 13 days have passed since your last dose was given, call your healthcare provider right away for dosing instructions.
If you miss 1 or more doses of maintenance dose of 300 mg of HYMPAVZI:
o
Give a dose as soon as possible, and then continue with your 300 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.
Download Prescribing Information

Health Professional Information

How should I use HYMPAVZI?

How should I use HYMPAVZI?

See the detailed “Instructions for Use” that comes with your HYMPAVZI for information on how to inject a dose of HYMPAVZI, and how to properly throw away (dispose of) used HYMPAVZI prefilled syringe or HYMPAVZI prefilled pen.

Use HYMPAVZI exactly as prescribed by your healthcare provider.
Your healthcare provider will provide instructions for stopping (discontinuing) your current treatment when switching from factor- or non-factor-based medicines to HYMPAVZI.
HYMPAVZI is given as an injection under your skin (subcutaneous injection) by you or your caregiver.
Your healthcare provider should show you or your caregiver how to inject HYMPAVZI before you inject yourself for the first time.
Do not attempt to inject yourself or another person unless you have been taught how to do so by a healthcare provider.
Your first dose (loading dose) of HYMPAVZI is 300 mg (two 150 mg injections). Then you will inject a weekly (maintenance) dose as prescribed by your healthcare provider.
Inject HYMPAVZI 1 time a week on the same day each week. Inject HYMPAVZI at any time of day.
Your healthcare provider will provide information on the treatment of breakthrough bleeding during your treatment with HYMPAVZI. Do not use HYMPAVZI to treat breakthrough bleeding.
If you miss a maintenance dose of 150 mg of HYMPAVZI:
o
Give the dose as soon as possible before the next scheduled dose, and then continue with your usual 150 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.
o
If more than 13 days have passed since your last dose was given, call your healthcare provider right away for dosing instructions.
If you miss 1 or more doses of maintenance dose of 300 mg of HYMPAVZI:
o
Give a dose as soon as possible, and then continue with your 300 mg weekly dosing schedule. You may inject your next dose at your regularly scheduled time or continue dosing based on the new day you injected your missed dose. In case you are not sure when to inject HYMPAVZI, call your healthcare provider.

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.